Extracellular Vesicles in Cardiac Regeneration: Potential Applications for Tissues-on-a-Chip.
Trends Biotechnol
; 39(8): 755-773, 2021 08.
Article
em En
| MEDLINE
| ID: mdl-32958383
Strategies to regenerate cardiac tissue postinjury are limited and heart transplantation remains the only 'cure' for a failing heart. Extracellular vesicles (EVs), membrane-bound cell secretions important in intercellular signaling, have been shown to play a crucial role in regulating heart function. A mechanistic understanding of the role of EVs in the heart remains elusive due to the challenges in studying the native human heart. Tissue-on-a-chip platforms, comprising functional, physiologically relevant human tissue models, are an emerging technology that has yet to be fully applied to the study of EVs. In this review, we summarize recent advances in cardiac tissue-on-a-chip (CTC) platforms and discuss how they are uniquely situated to advance our understanding of EVs in cardiac disease and regeneration.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Regeneração
/
Dispositivos Lab-On-A-Chip
/
Vesículas Extracelulares
/
Coração
Limite:
Humans
Idioma:
En
Revista:
Trends Biotechnol
Ano de publicação:
2021
Tipo de documento:
Article
País de afiliação:
Canadá
País de publicação:
Reino Unido